Published in J Immunol on November 15, 2000
Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis. Infect Immun (2008) 1.26
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis. J Anat (2004) 1.22
Genetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibility. Hum Genet (2009) 1.00
Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice. J Neuroinflammation (2008) 0.97
STAT-6-mediated control of P-selectin by substance P and interleukin-4 in human dermal endothelial cells. Am J Pathol (2006) 0.89
Abeta-immunotherapy for Alzheimer's disease using mannan-amyloid-Beta peptide immunoconjugates. DNA Cell Biol (2006) 0.82
Dextran induces differentiation of circulating endothelial progenitor cells. Physiol Rep (2014) 0.81
Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice. J Inherit Metab Dis (2015) 0.80
The role of pattern recognition receptors in the innate recognition of Candida albicans. Virulence (2015) 0.77
Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics. Int J Pharm Investig (2014) 0.75
Longitudinal monitoring of skin accumulation of nanocarriers and biologicals with fiber optic near infrared fluorescence spectroscopy (FONIRS). J Control Release (2017) 0.75
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol (2000) 3.77
Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med (2001) 3.74
Epidermal Langerhans cells--a target for HTLV-III/LAV infection. J Invest Dermatol (1987) 3.41
Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol (1995) 3.34
Epidermal Langerhans cells bear Fc and C3 receptors. Nature (1977) 3.21
Diagnostic accuracy of dermoscopy. Lancet Oncol (2002) 3.14
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med (1987) 3.13
Identification of bacteria in a biodegraded wall painting by denaturing gradient gel electrophoresis of PCR-amplified gene fragments coding for 16S rRNA. Appl Environ Microbiol (1996) 2.95
Methicillin-resistant Staphylococcus aureus susceptibility testing by an automated system, Autobac I. Antimicrob Agents Chemother (1978) 2.79
Frequency and characteristics of enlarging common melanocytic nevi. Arch Dermatol (2000) 2.75
Impact of landscape management on the genetic structure of red squirrel populations. Science (2001) 2.34
Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol (1981) 2.28
Expression of Thy-1 antigen by murine epidermal cells. J Invest Dermatol (1983) 2.20
Phototesting and dosimetry for photochemotherapy. Br J Dermatol (1977) 2.17
Neuroperception. Early visual experience and face processing. Nature (2001) 1.97
In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol (1987) 1.90
Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J Exp Med (1999) 1.89
Lysis of Escherichia coli by induction of cloned phi X174 genes. Mol Gen Genet (1982) 1.88
Ecstasy pill testing: harm minimization gone too far? Addiction (2001) 1.85
Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group. J Clin Oncol (1998) 1.82
The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol (2001) 1.80
The fine structure of the Langerhans cell granule. J Cell Biol (1967) 1.79
Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med (1992) 1.77
Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med (1984) 1.75
Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet (2000) 1.68
The langerhans cell. Curr Probl Dermatol (1972) 1.67
Wells' syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol (1988) 1.62
Methadone maintenance and tuberculosis treatment. BMJ (1996) 1.61
Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques. J Invest Dermatol (1991) 1.60
Antigen presentation by murine epidermal langerhans cells and its alteration by ultraviolet B light. J Immunol (1981) 1.60
Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol (1997) 1.60
Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor. J Exp Med (1990) 1.57
Ultrastructural localization of immunoglobulins in bullous pemphigoid skin. Employment of a new peroxidase-antiperoxidase multistep method. J Invest Dermatol (1975) 1.57
Uptake, intracellular transport and degradation of exogenous protein by Langerhans cells. An electron microscopic-cytochemical study using peroxidase as tracer substance. J Invest Dermatol (1970) 1.56
Permeability of the epidermis and the phagocytic activity of keratinocytes. Ultrastructural studies with thorotrast as a marker. J Ultrastruct Res (1971) 1.55
[Odland bodies (Membrane coating granules, keratinosomes) as epidermal lysosomes. An electron microscopic-cytochemical contribution on the cornification process of the skin]. Arch Klin Exp Dermatol (1967) 1.51
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat Med (1998) 1.50
Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol (1999) 1.50
An advanced molecular strategy to identify bacterial communities on art objects. J Microbiol Methods (2001) 1.49
Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine. Eur J Cancer (1998) 1.48
Treatment of psoriatic arthritis by extracorporeal photochemotherapy. Br J Dermatol (1990) 1.47
Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem (1998) 1.47
Developmental changes in the scanning of faces by young infants. Child Dev (1976) 1.46
Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol (1991) 1.43
Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood (1996) 1.42
Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis. J Am Acad Dermatol (1987) 1.42
Erythema multiforme associated human autoantibodies against desmoplakin I and II: biochemical characterization and passive transfer studies into newborn mice. J Invest Dermatol (1998) 1.41
Statistical evaluation of epiluminescence microscopy criteria for melanocytic pigmented skin lesions. J Am Acad Dermatol (1993) 1.41
Substance misuse among health care workers: national survey of occupational physicians. Occup Med (Lond) (2012) 1.40
Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest (1995) 1.40
[Photochemotherapy of psoriasis: clinical experiences with 152 patients (author's transl)]. Dtsch Med Wochenschr (1975) 1.38
Molecular analysis of plant migration and refugia in the Arctic. Science (2000) 1.37
Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc Natl Acad Sci U S A (1994) 1.36
Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department. J Accid Emerg Med (1999) 1.35
Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein E. J Bacteriol (1990) 1.35
Interleukin-3 is a differentiation factor for human basophils. Blood (1989) 1.34
MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol (1997) 1.32
Quantitative studies on the Langerhans cell population of guinea pig epidermis. J Invest Dermatol (1967) 1.31
The missing link in phage lysis of gram-positive bacteria: gene 14 of Bacillus subtilis phage phi 29 encodes the functional homolog of lambda S protein. J Bacteriol (1993) 1.31
[The Langerhans cells. Results of newer experimental studies. I]. Arch Klin Exp Dermatol (1967) 1.30
Langerhans cells as stimulator cells in the murine primary epidermal cell-lymphocyte reaction: alteration by UV-B irradiation. J Invest Dermatol (1982) 1.30
Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) by HLA typing. Lancet (1979) 1.30
Protein-cofactor interactions in bacterial reaction centers from Rhodobacter sphaeroides R-26: II. Geometry of the hydrogen bonds to the primary quinone formula by 1H and 2H ENDOR spectroscopy. Biophys J (2006) 1.29
P45, an extracellular 45 kDa protein of Listeria monocytogenes with similarity to protein p60 and exhibiting peptidoglycan lytic activity. Arch Microbiol (2000) 1.27
Generalized atrophic benign epidermolysis bullosa. Arch Dermatol (1982) 1.27
Langerhans' cells are an actual site of HIV-1 replication. Intervirology (1988) 1.27
Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol (1997) 1.25
An electron microscopic study on the extraneous coat of keratinocytes and the intercellular space of the epidermis. J Invest Dermatol (1968) 1.24
Ultrastructural localization of nucleoside triphosphatase in Langerhans cells. J Invest Dermatol (1967) 1.22
Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes. Br J Clin Pharmacol (1999) 1.21
Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J Exp Med (2001) 1.21
Cannabis use in patients with multiple sclerosis. Mult Scler (2006) 1.21
Ultrastructural localization of pemphigus autoantibodies within e epidermis. Nature (1971) 1.21
Mechanism of UV-B-induced impairment of the antigen-presenting capacity of murine epidermal cells. J Immunol (1983) 1.20
Induction of UV light tolerance by PUVA in patients with polymorphous light eruption. Br J Dermatol (1978) 1.20
Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli. Arch Microbiol (1992) 1.20
In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma. J Am Acad Dermatol (1987) 1.19
How carotenoids protect bacterial photosynthesis. Philos Trans R Soc Lond B Biol Sci (2000) 1.19
Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest (1998) 1.19
Lysis of Escherichia coli by cloned phi X174 gene E depends on its expression. J Gen Microbiol (1985) 1.19
Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases. J Invest Dermatol (1981) 1.17
Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol (2000) 1.17
Sequence analysis of the sbsA gene encoding the 130-kDa surface-layer protein of Bacillus stearothermophilus strain PV72. Gene (1994) 1.17
[The permeability of the intercellular space of the epidermis for low molecular weight protein. Electron microscopic cytochemical studies with peroxidase as a tracer substance]. Arch Klin Exp Dermatol (1969) 1.17
Photoprotective effect of a psoralen-UVA-induced tan. Arch Dermatol Res (1978) 1.17
Interleukin 2 receptors on cultured murine epidermal Langerhans cells. J Immunol (1986) 1.16
Clinical and histopathological aspects of cutaneous mastocytosis. Leuk Res (2001) 1.16
Leu-3/T4 expression on epidermal Langerhans cells in normal and diseased skin. J Invest Dermatol (1986) 1.16
Bacterial ghosts: non-living candidate vaccines. J Biotechnol (1996) 1.16
Development of spatial and temporal vision during childhood. Vision Res (1999) 1.15
[Uptake, intracellular transport, and degradation of exogenous protein by keratinocytes. Electron microscopy and cytochemical study using peroxidase as a tracer substance]. Arch Klin Exp Dermatol (1969) 1.15
Molecular characterization of the Bacillus stearothermophilus PV72 S-layer gene sbsB induced by oxidative stress. J Bacteriol (1997) 1.15
MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol (1993) 1.15
CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. J Immunol (1999) 1.15
Epidermal lysosomes. Electron microscopic-cytochemical studies. Arch Dermatol (1970) 1.15
Generalized eruptive histiocytoma. Enzyme histochemistry and electron microscopy. Arch Dermatol (1967) 1.14
Biochemical characterization of phi X174-protein-E-mediated lysis of Escherichia coli. Eur J Biochem (1989) 1.14
Electronic structure of Q-A in reaction centers from Rhodobacter sphaeroides. I. Electron paramagnetic resonance in single crystals. Biophys J (1995) 1.14